Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Mallinckrodt
Harvard Business School
Merck
Boehringer Ingelheim

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR TAUVID


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Tauvid

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01992380 ↗ A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects Completed Avid Radiopharmaceuticals Phase 1 2013-11-13 This study will test if two flortaucipir PET scans up to 4 weeks apart in healthy volunteers, MCI and AD subjects provide the same results.
NCT02167594 ↗ Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers Completed Avid Radiopharmaceuticals Phase 1 2014-08-12 This study will evaluate flortaucipir for brain imaging of tau in subjects with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and healthy volunteers.
NCT02278354 ↗ Tau Imaging in Professional Fighters Completed The Cleveland Clinic Phase 1 2015-02-18 Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) will receive flortaucipir to explore its use as a biomarker for brain injury related to repetitive head trauma and to examine the relationship between clinical presentation and tau deposition.
NCT02278354 ↗ Tau Imaging in Professional Fighters Completed Avid Radiopharmaceuticals Phase 1 2015-02-18 Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) will receive flortaucipir to explore its use as a biomarker for brain injury related to repetitive head trauma and to examine the relationship between clinical presentation and tau deposition.
NCT02278367 ↗ Clinical Evaluation of Flortaucipir F 18 Completed Avid Radiopharmaceuticals Phase 2 2014-12-01 This study is designed to expand the database of flortaucipir F 18 safety and tau binding as measured by PET imaging and to provide standardized conditions for flortaucipir PET use, data collection and analysis to facilitate companion studies including, but not limited to, longitudinal studies of aging, depression, and traumatic brain injury.
NCT02336360 ↗ Augmenting Flortaucipir Dosimetry Estimates Completed Avid Radiopharmaceuticals Phase 1 2015-01-01 This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.
NCT03040713 ↗ Flortaucipir PET Imaging in Subjects With FTD Completed Avid Radiopharmaceuticals Phase 1 2017-04-11 This study is designed to assess the usefulness of flortaucipir in Positron Emission Tomography (PET) imaging for subjects diagnosed with Frontotemporal Dementia (FTD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tauvid

Condition Name

Condition Name for Tauvid
Intervention Trials
Alzheimer's Disease 4
Alzheimer Disease 2
Cognitive Decline 1
Corticobasal Degeneration 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tauvid
Intervention Trials
Alzheimer Disease 6
Dementia 2
Cognitive Dysfunction 2
Aphasia, Primary Progressive 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tauvid

Trials by Country

Trials by Country for Tauvid
Location Trials
United States 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tauvid
Location Trials
Connecticut 4
California 4
Texas 2
Nevada 2
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tauvid

Clinical Trial Phase

Clinical Trial Phase for Tauvid
Clinical Trial Phase Trials
Phase 2 1
Phase 1 7
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tauvid
Clinical Trial Phase Trials
Completed 8
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tauvid

Sponsor Name

Sponsor Name for Tauvid
Sponsor Trials
Avid Radiopharmaceuticals 9
The Cleveland Clinic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tauvid
Sponsor Trials
Industry 9
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Baxter
Medtronic
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.